GHR and non-small cell lung carcinoma: Transcriptomic analysis of 515 NSCLC tumors (238 males and 277 females) from the TCGA dataset revealed a significant positive correlation (FDR ≤ 0.05; Pearson’s correlation) between GHR expression and genes associated with therapy resistance and disease progression.